ROSE LifeScience announced that it will add HEXO‘s (HEXO) Quebec portfolio to ROSE’s industry leading commercialization and distribution services business. Headquartered in Gatineau, Quebec, HEXO delivers premium cannabis experiences that inspire customer loyalty, from recreational to therapeutic products. HEXO’s products balance THC with CBD, terpene levels and flavonoids, to create high-quality, clean, consistent customer favourites. HEXO’s state-of-the-art facilities in Masson-Angers, Quebec are purpose-built and engineered to provide exceptional capacity and streamlined operations, developing innovative products to serve the cannabis market in Quebec, across Canada and globally. ROSE’s commercialization and distribution expertise will help to position HEXO’s Quebec portfolio for further expansion in the province, complementing ROSE’s relationship with Tilray Brands, (TLRY), a long-standing ROSE commercialization and distribution partner.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HEXO: